Trijardy® XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets)
for Diabetes Type 2

Trijardy XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets) is a prescription medication combining empagliflozin, linagliptin, and metformin to help control blood sugar levels in adults with type 2 diabetes. Used alongside diet and exercise, it improves blood sugar control and reduces the risk of death from heart attack, stroke, or heart failure in those with type 2 diabetes and heart disease.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Diabetes Type 2